PTEN: a new dawn in Parkinson’s disease treatment
In recent years, the study of phosphatase and tension homolog (PTEN) has gradually become a research hotspot. As an important oncogene, the role of PTEN in cancer has long been widely recognized and intensively studied, but it has been relatively less studied in other diseases. Parkinson’s disease (...
Saved in:
| Main Authors: | Xinghuang Yang, Tianqi Liu, Hong Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Cellular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2025.1497555/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy
by: David J. Rademacher, et al.
Published: (2025-06-01) -
Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena
by: Gülseren Evirgen Şahin, et al.
Published: (2022-08-01) -
Evaluation of social deprivation as a modifier of phenotypic divergence in PTEN Hamartoma Tumor Syndrome
by: Parker L. Bussies, et al.
Published: (2025-01-01) -
How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01) -
Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells
by: Kinga Wilkus-Adamczyk, et al.
Published: (2024-12-01)